Cite

HARVARD Citation

    Yi, J. et al. (n.d.). LBA13Clinical outcomes of ibrutinib in patients with relapsed or refractory mantle cell lymphoma: Korean multicenter, retrospective analysis. Annals of oncology. p. . [Online]. 
  
Back to record